NTRA
NTRA
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
0
$0
Insider Sales
9
$70.37M
Total Volume
$70.37M
10 transactions
Net Activity
$70.37M
Net selling
Sentiment Rating
Heavy DistributionCEO Conviction Index
Liquidating / Profit Taking
Key Drivers
- •Heavy distribution: sales represent 100% of total transaction value.
- •CEO selling activity detected. Often driven by option expiration or diversification plans.
- •Significant liquidation: total sale value exceeds $10M.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Rabinowitz Matthew
Exec COB
$55.45M total
Sheena Jonathan
CO-FOUNDER
$8.78M total
Chapman Steven Leonard
CEO, Pres
$3.95M total
Moshkevich Solomon
Pres, CLINICALDIAGNOSTICS
$1.40M total
Brophy Michael Burkes
CFO
$1.31M total
Quick Actions
NTRA has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%. NTRA ranks #192 in insider activity out of 569 tracked companies in its industry.
Over the last 90 days, corporate insiders at NTRA (NTRA) engaged in a total of 10 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 9 were sales. The total volume of insider trading reached $70.37M.
The net insider activity for NTRA shows a net selling bias of $70.37M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Rabinowitz Matthew (Exec COB), who traded 102.0K shares valued at $34.80M on Sep 14, 2026.
Natera, Inc. (NTRA) Stock Price, News, Quote & History
Natera, Inc. (NTRA) stock price, news, quote and history
Why Is Natera Stock Up Nearly 41% Since May?
UBS reiterates Natera stock rating on CEO transition confidence By Investing.com
AI Takes On Cancer Detection From a Single Blood Draw (MEDS, ANT, GH, GRAL, NTRA, FRNM)
Weekly Recap: $6B 2029 revenue target and CFO projects $3B+ in 2026
Related News & Analyst Reports
Read original insights and educational research covering NTRA and the Unknown sector.
Evaluating Insider Buying in Distressed Debt and Turnaround Situations
When a company is in financial distress, standard valuation metrics break down. This guide explains how to evaluate insider buying signals in turnaround and distressed scenarios — including what makes them more or less credible, which insiders to watch, and how to size positions in high-risk situations.
Analyzing Insider Buying Trends in the Aerospace and Defense Sector
Defense contractors face unique trading restrictions tied to classified contracts. This report maps insider buying at Lockheed Martin, RTX, and L3Harris against DoD budget cycles and earnings surprises.
How to Interpret Insider Buys in Distressed Debt Scenarios
When a company is near default, insider equity purchases are highly ambiguous. This guide explains how to read Form 4 buys in distressed situations, distinguishing rescue capital from genuine conviction versus contractual obligations.
FAQs About NTRA Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for NTRA.